Stem cell treatment for vascular diseases can be predicted through real-time observation

IMAGE: (A) For the bioorthogonal labeling, unnatural azide groups on the hEPC surface are generated with Ac4ManNAz pretreatment. Then, azide groups of hEPCs are labeled with DBCO-Cy5 via bioorthogonal copper-free click… view more  Credit: Korea Institute of Science and Technology(KIST) In recent years, the number of high-risk groups for ischemic diseases such as critical limb ischemia […]